These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 2167171

  • 1. Significance of viral coinfections by HIV, HTLV-I, Epstein-Barr virus, and cytomegalovirus for immunological abnormalities in hemophiliacs.
    Okubo S, Yasunaga K.
    Cancer Detect Prev; 1990; 14(3):343-6. PubMed ID: 2167171
    [Abstract] [Full Text] [Related]

  • 2. Significance of viral co-infections by HIV, HTLV-1, Epstein-Barr virus and cytomegalovirus for immunological conditions in Japanese hemophiliacs.
    Okubo S, Yasunaga K.
    AIDS; 1988 Aug; 2(4):318-9. PubMed ID: 2846005
    [No Abstract] [Full Text] [Related]

  • 3. [The latent Epstein-Barr virus (EBV) activation and EBV-specific immunological abnormality in human immunodeficiency virus (HIV) infected hemophiliacs].
    Matsuura A.
    Hokkaido Igaku Zasshi; 1989 Jul; 64(4):474-83. PubMed ID: 2555293
    [Abstract] [Full Text] [Related]

  • 4. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
    Kwon KW.
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
    [Abstract] [Full Text] [Related]

  • 5. Viral coinfections among African children infected with human immunodeficiency virus type 1.
    Chakraborty R, Rees G, Bourboulia D, Cross AM, Dixon JR, D'Agostino A, Musoke R, Boshoff C, Rowland-Jones SL, Klenerman P.
    Clin Infect Dis; 2003 Apr 01; 36(7):922-4. PubMed ID: 12652394
    [Abstract] [Full Text] [Related]

  • 6. Coinfection with herpesviruses in young children of HIV-infected women.
    Sever JL, Rakusan TA, Ellaurie M, Frenkel N, Wyatt LS, Campos JM, O'Donnell RM, Price MV.
    Pediatr AIDS HIV Infect; 1995 Apr 01; 6(2):75-82. PubMed ID: 11361384
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD.
    J Med Virol; 2002 Jul 01; 67(3):320-6. PubMed ID: 12116021
    [Abstract] [Full Text] [Related]

  • 8. Positive Epstein-Barr virus and cytomegalovirus IgM assays in primary HIV infection.
    Post JJ, Chan MK, Whybin LR, Shi Q, Rawlinson WD, Cunningham P, Robertson PW.
    J Med Virol; 2011 Aug 01; 83(8):1406-9. PubMed ID: 21678445
    [Abstract] [Full Text] [Related]

  • 9. Analysis of cytomegalovirus and Epstein-Barr virus antibody responses in treated hemophiliacs. Implications for the study of acquired immune deficiency syndrome.
    Cheeseman SH, Sullivan JL, Brettler DB, Levine PH.
    JAMA; 1984 Jul 06; 252(1):83-5. PubMed ID: 6328057
    [Abstract] [Full Text] [Related]

  • 10. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
    Nagy J, Haikin H, Sarov B, Háber A, Kun L, Sarov I.
    Acta Microbiol Immunol Hung; 1995 Jul 06; 42(2):179-87. PubMed ID: 7551711
    [Abstract] [Full Text] [Related]

  • 11. High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections.
    Jin X, Demoitie MA, Donahoe SM, Ogg GS, Bonhoeffer S, Kakimoto WM, Gillespie G, Moss PA, Dyer W, Kurilla MG, Riddell SR, Downie J, Sullivan JS, McMichael AJ, Workman C, Nixon DF.
    J Infect Dis; 2000 Jan 06; 181(1):165-75. PubMed ID: 10608763
    [Abstract] [Full Text] [Related]

  • 12. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K.
    J Med Virol; 1998 Nov 06; 56(3):186-91. PubMed ID: 9783683
    [Abstract] [Full Text] [Related]

  • 13. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
    Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K.
    Br J Dermatol; 2006 Aug 06; 155(2):344-9. PubMed ID: 16882173
    [Abstract] [Full Text] [Related]

  • 14. Immunological and virological status of a hemophiliac infected with human T cell lymphotropic virus type 1 and human immunodeficiency virus type 1, and results of therapy.
    Murakami T, Hattori T, Maeda Y, Matsushita S, Kannagi M, Sagawa K, Takatsuki K.
    Int J Hematol; 1991 Feb 06; 54(1):85-90. PubMed ID: 1954356
    [Abstract] [Full Text] [Related]

  • 15. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
    Naveau S, Delfraissy JF, Poitrine A, Poynard T, Chaput JC.
    Gastroenterol Clin Biol; 1985 Feb 06; 9(2):109-12. PubMed ID: 2984075
    [Abstract] [Full Text] [Related]

  • 16. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
    Dolcetti R, Di Luca D, Carbone A, Mirandola P, De Vita S, Vaccher E, Sighinolfi L, Gloghini A, Tirelli U, Cassai E, Boiocchi M.
    J Med Virol; 1996 Apr 06; 48(4):344-53. PubMed ID: 8699167
    [Abstract] [Full Text] [Related]

  • 17. [The effect of cytomegalovirus and Epstein-Barr virus infection on immunologic signs].
    Korcáková L, Vrubel J, Kaslík J, Nozicková M.
    Vnitr Lek; 1989 Oct 06; 35(10):987-91. PubMed ID: 2559543
    [Abstract] [Full Text] [Related]

  • 18. Antibodies to Epstein-Barr virus-induced early antigens in blood donors.
    Wohlrabe P, Färber I, Wutzler P, Uhlig R.
    Acta Virol; 1989 Aug 06; 33(4):344-8. PubMed ID: 2574941
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Aug 06; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 20. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM.
    AIDS; 2007 Oct 18; 21(16):2141-9. PubMed ID: 18090040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.